Balanced news tone
News Sentiment
PRTC sentiment intelligence
PureTech Health plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
89/100 classification confidence.
directly relevant articles
high-authority source matches
-0.2% over one week, -8.5% over four weeks, trend inactive, and below fair value.
PureTech Subsidiary Celea Begins Phase 3 IPF Study Comparing Deupirfenidone With Standard Therapy (PRTC)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
PureTech Subsidiary Celea Begins Phase 3 IPF Study Comparing Deupirfenidone With Standard Therapy (PRTC)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 07:16
- Source
- Market source
REG - PureTech Health PLC - PRTC: Celea Doses 1st Patient in Phase 3 IPF Trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 06:00
- Source
- TradingView
DIRECTOR DEALINGS: PureTech Health directors buy GBP176,000 in shares
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Jul 2026 15:37
- Source
- London South East
REG - PureTech Health PLC - Director/PDMR Shareholding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 06:00
- Source
- TradingView
PureTech Health (PRTC) Edges Higher as Shares Hold Above Key Support - Extension Target
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 08 Jul 2026 21:31
- Source
- dars.gov.et
PRTC Stock Price and Chart — LSE:PRTC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- TradingView
REG - PureTech Health PLC - PRTC Launches Celea: $180M & Asset Transfer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 06:00
- Source
- TradingView
PureTech Health PLC Actuals & Estimates (LSE:PRTC)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 20:06
- Source
- TradingView
PureTech Health ADR (PRTC) Edges Higher Amidst Modest Uptick - Institutional Buy Signals
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- DonanımHaber
PureTech Health PLC (PRTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 12:53
- Source
- TradingKey
PureTech Health plc (PRTC) Q4 2024 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Advances Pipeline - Tangible Book Value
- Tone
- Negative 15/100
- Event
- Earnings
- Published
- 07 Jun 2026 07:00
- Source
- Bölüm Sonu Canavarı
PureTech Health (PRTC) Holds Steady at $17.25 – Consolidation or Calm Before a Move? - Fibonacci Fan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- DonanımHaber
PureTech Health Plc (LSE:PRTC) Share Price, History, & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 06:08
- Source
- The Twelfth Magpie
PureTech Health plc (PRTC) Stock Analysis: Navigating the Biotech Landscape with Clinical Innovations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 23:43
- Source
- DirectorsTalk Interviews
PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Proactive Investors
PureTech Health to delist ADSs from Nasdaq, focus on LSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- Investing.com
PureTech Announces Annual Results for Year Ended December 31, 2025
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Apr 2026 07:00
- Source
- BioSpace
PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- Business Wire
PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Business Wire
Is PureTech Health in FTSE AIM 100?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- Kalkine Media
PureTech Health plc (LON:PRTC) is favoured by institutional owners who hold 73% of the company
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jan 2026 08:00
- Source
- Market source
Recent uptick might appease PureTech Health plc (LON:PRTC) institutional owners after losing 12% over the past year
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Sep 2025 07:00
- Source
- simplywall.st
SUNDAY NEWSPAPER SHARE TIPS: PureTech Health, Centamin, Ibstock and JD Wetherspoon
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2016 07:00
- Source
- This is Money
PureTech’s long view on biopharma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Aug 2015 07:00
- Source
- The Boston Globe